stars 1 stars 2 stars 3

BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of this AI platform, its scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers the Company’s in-house drug pipeline and supports successful collaborations with AstraZeneca, as well as leading research and charitable institutions.

View Top Employees from BenevolentAI
Revenue $21 million
Funding $115 million
Employees 439 (439 on RocketReach)
Founded 2013
Phone +44 20 3781 9360
JavaScript, HTML, PHP +24 more (view full list)
Category Biotechnology, Biotechnology Research, Business Services General, Drug Discovery, Artificial Intelligence, Business Services, Science and Engineering, Drug Development, Nutraceutical, Health Care
Web Rank 1 Million
Keywords benevolentai, benevolent ai, benevolent tech, bioinformatics chemoinformatics startup, benevolentai janssen
SIC 73, 737, 7372
NAICS 511210, 511, 5112, 51121, 51

BenevolentAI Questions

The BenevolentAI annual revenue was $21 million in 2023.

Joanna Shields is the CEO of BenevolentAI.

439 people are employed at BenevolentAI.

The NAICS codes for BenevolentAI are [511210, 511, 5112, 51121, 51].

The SIC codes for BenevolentAI are [73, 737, 7372].

Top BenevolentAI Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users